The American healthcare system is currently facing a crisis of affordability and efficiency, characterized by rising costs and a fragmented delivery model that often prioritizes volume over value. Faisal Zain, a prominent healthcare expert specializing in medical technology and device innovation, joins us to discuss the urgent need for systemic reform. With extensive experience in navigating the complexities of medical manufacturing and diagnostic advancements, Zain offers a unique perspective on how federal intervention and technological integration can reshape the industry. Today, we explore the “Worthy” initiative’s vision for a redesigned pharmaceutical supply chain, the democratization of patient data, and the transition toward a healthcare system that operates within a sustainable budget while delivering personalized care.
The current healthcare landscape is often described as dysfunctional and financially unsustainable for the average family. Why is internal industry reform insufficient to fix these systemic issues, and what specific legislative steps are necessary to compel private organizations to prioritize patient health outcomes over profit margins?
The reality is that the healthcare system is currently failing us and, in many ways, is effectively bankrupting families who cannot keep up with the soaring costs. Internal reform is insufficient because the status quo is deeply entrenched; the industry is remarkably good at moving only when it absolutely has to, and right now, the incentives are aligned toward maintaining the current dysfunctional state. We need the federal government to step up and enact bold, systemic reforms that go beyond incremental changes. This involves passing a series of laws and regulations that force all players to put patients over profits, making it so that doing the right thing for the patient is the only way to have a viable healthcare business and earn an income. By setting a national budget and establishing strict standards for affordability, we can compel organizations to move away from the “do more, get paid more” mentality that currently plagues our system.
Traditional pharmacy benefit models frequently rely on rebates, spread pricing, and complex fee structures that can inflate drug costs. How would eliminating these financial incentives reshape the pharmaceutical supply chain, and what are the practical challenges of transitioning the entire industry to a transparent, cost-plus distribution model?
Eliminating kickbacks in the form of rebates, fees, and spread pricing would fundamentally break the flawed pharmacy care model that has existed for decades. Currently, the system rewards complexity over clarity, but moving to a transparent cost-plus model—similar to what we see with Amazon Pharmacy or Mark Cuban Cost Plus Drug Company—would strip away the “noise” and unnecessary costs that inflate prices for the end user. The practical challenge lies in the power of the “big three” pharmacy benefit managers who have vast resources and deeply entrenched interests in maintaining the current structure. However, by gaining a coalition of persistent voices and advocating for federal legislation that prohibits services charged based on drug prices or volume, we can create a pragmatic path toward affordability. Once the federal government “moves the cheese” by changing how companies get paid, the industry will adapt much faster than most people anticipate.
Many health systems struggle with data sharing, yet patients often lack direct access to their own medical history. How can we shift toward a national standard where patients have total ownership of their real-time digital records, and what obstacles must be removed to make this data flow seamless?
We need to move past the concept of “interoperability,” which I often describe as a journey without a destination that celebrates low expectations, and instead move toward a single national standard for digital health records. The core principle must be that your medical data belongs to you, and you shouldn’t have to ask permission to access it. To make this flow seamless, we must advocate for federal laws that require every provider to share all patient data in real-time, creating a comprehensive digital record accessible to both the patient and their care team. The biggest obstacle is the fragmentation of current regulations and the lack of a unified technical mandate that forces all systems to talk to each other without exception. Once a patient has their full history at their fingertips, they are no longer just a passive participant but a partner in their own care journey.
Administrative tasks like prior authorization, billing, and claims settlement consume massive resources and create provider burnout. How can artificial intelligence and advanced automation be responsibly integrated to streamline these workflows, and what measurable impact would this have on the quality of personalized care for patients?
Responsible use of artificial intelligence can automate nearly every administrative friction point, including prior authorization, billing, provider directory updates, and routine patient questions. By leveraging AI to handle these data-heavy, repetitive tasks, we can effectively expunge the “chronic illness of low expectations” that defines our current administrative processes. This shift would have a measurable impact by freeing up clinicians to focus on high-touch, personalized care rather than paperwork, reducing the burnout that currently sidelines so many talented professionals. Furthermore, when these processes are automated, the speed of care delivery increases, and the financial waste—which currently eats into the resources available for actual treatment—is significantly reduced. It simplifies the entire ecosystem, making it more agile and responsive to the actual needs of the patient.
Rapid shifts in telemedicine adoption demonstrated that the industry can transform quickly when financial incentives change. How can federal policy accelerate the transition away from the “do more, get paid more” fee-for-service model, and what does a successful healthcare system operating under a fixed budget look like?
Telemedicine proved that when the payment structure changes, clinicians can adapt in days or weeks rather than decades; we must apply that same urgency to the broader fee-for-service model. Federal policy can accelerate this transition by shifting the reimbursement structure to pay for health outcomes rather than the volume of services rendered. A successful system operating under a fixed budget would prioritize preventative care and efficiency, as there would no longer be a financial reward for redundant testing or unnecessary procedures. This “Worthy” approach essentially puts the entire healthcare system on a diet, forcing organizations to innovate within a set financial framework. It shifts the focus from how many patients can be processed to how many patients can be kept healthy and out of the hospital.
Personalized care relies on shared decision-making where patients and clinicians use data to weigh treatment pros and cons. How do we move from a one-size-fits-all clinical approach to this collaborative model, and what specific metrics indicate that this shift actually lowers costs while improving patient satisfaction?
The move to shared decision-making requires that we provide both patients and clinicians with the tools to analyze digital health records alongside global medical knowledge, often using AI to lay out the pros and cons of various treatments. Instead of a doctor simply prescribing a standard protocol, the clinician and patient engage in a dialogue where the decision is tailored to the individual’s specific condition and life goals. Research consistently shows that when this collaborative model is in place, the quality outcomes are better and patient satisfaction scores rise significantly because the patient feels heard and involved. Most importantly, costs are generally lower because informed patients often opt for more effective, less invasive paths rather than the high-cost, high-volume treatments that the old system encouraged. It replaces a one-size-fits-all approach with a targeted, evidence-based conversation.
What is your forecast for the national healthcare policy reform movement?
I believe we are at a tipping point where the public’s frustration over affordability has reached a critical mass that elected officials can no longer ignore. While the immediate political cycle may delay decisive action this year, the underlying sentiment that the status quo is unacceptable is only growing stronger. My forecast is that we will see a long-term, nonpartisan movement—much like the successful social-political movements of our past—that eventually forces the federal government to adopt a “Worthy” standard of care. Over the next few years, I expect to see a series of legislative wins that begin with radical transparency in drug pricing and move toward a unified national digital health record system. Progress won’t be measured in weeks or months, but the persistence of a coalition involving employers, media, and the public will eventually break the gridlock and build a system truly worthy of our families and friends.
